Growth & Lifecycle Management

Know where your next
opportunity is emerging

Know what others can’t by connecting longitudinal clinical and commercial signals to reveal where the market is changing and where opportunity is emerging.

As your brand matures, new patients, treatment patterns, outcomes and competitive dynamics continue to emerge. Connect longitudinal clinical and commercial signals to see where the market is changing — and where the evidence points to your next opportunity.

Discuss your use case

ILLUSTRATIVE SCENARIO

What is driving population change over time?

Why this decision matters

The market doesn’t stop changing once a therapy launches. New patient populations emerge. Treatment patterns shift. Competitors enter. Evidence accumulates. Access conditions change.

The opportunity you sized at launch may not be the opportunity that exists several years later. Understanding how patients, outcomes and the market are changing can reveal where to expand, where to defend and where strategy needs to change.

Know which types of decisions are enabled at this stage

Brand / Portfolio

Where is the next patient or market opportunity emerging?

HEOR

What long-term outcomes strengthen our value story — or reveal something new?

Medical Affairs

Where is real-world use changing, and what does that mean for evidence and education?

Market Access

How do we hold formulary position under IRA and payer consolidation?

Government Affairs

Where do we need RWE to defend price during Medicare negotiation?

What a conventional post-launch view may not tell you

Performance tracking can show how the brand is doing today. Individual RWE studies can answer specific evidence questions. Competitive intelligence can show what’s changing around you.

Viewed separately, they may not reveal where patient populations, outcomes, access and market dynamics are changing together, or where those changes create the next opportunity.

Diagram showing treatment, commercial, patient history, payer and clinical signals around a patient.

How our real-world data ecosystem helps you know what others can’t

Connect longitudinal patient, clinical, treatment, payer and commercial signals over time to understand:

Which patient populations are growing, changing or are underserved
How treatment patterns and outcomes differ across clinically meaningful subpopulations
Where real-world evidence could support indication expansion or a stronger value story
Where competitive or access changes may put existing or future performance at risk

The same market can reveal a different opportunity when you start connecting longitudinal data.

Diagram showing treatment, commercial, clinical and payer signals converging into a connected patient view

Bring us your question

Ready to find the next growth opportunity?

Bring us your growth or lifecycle question and we’ll help connect longitudinal patient, clinical, treatment, payer and commercial signals to show where the market is changing.

Find your next growth opportunity

15-minute conversation with a HealthVerity expert

Know where your nextopportunity is emerging